These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 31910043)

  • 1. Toxicity and Efficacy Evaluation of an Adeno-Associated Virus Vector Expressing Codon-Optimized
    Dufour VL; Cideciyan AV; Ye GJ; Song C; Timmers A; Habecker PL; Pan W; Weinstein NM; Swider M; Durham AC; Ying GS; Robinson PM; Jacobson SG; Knop DR; Chulay JD; Shearman MS; Aguirre GD; Beltran WA
    Hum Gene Ther; 2020 Feb; 31(3-4):253-267. PubMed ID: 31910043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose Range Finding Studies with Two
    Song C; Dufour VL; Cideciyan AV; Ye GJ; Swider M; Newmark JA; Timmers AM; Robinson PM; Knop DR; Chulay JD; Jacobson SG; Aguirre GD; Beltran WA; Shearman MS
    Hum Gene Ther; 2020 Jul; 31(13-14):743-755. PubMed ID: 32414297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicology and Pharmacology of an AAV Vector Expressing Codon-Optimized RPGR in RPGR-Deficient Rd9 Mice.
    Song C; Conlon TJ; Deng WT; Coleman KE; Zhu P; Plummer C; Mandapati S; Van Hoosear M; Green KB; Sonnentag P; Sharma AK; Timmers A; Robinson PM; Knop DR; Hauswirth WW; Chulay JD; Shearman MS; Ye GJ
    Hum Gene Ther Clin Dev; 2018 Dec; 29(4):188-197. PubMed ID: 30280954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of Retinal Gene Therapy for X-Linked Retinitis Pigmentosa Due to RPGR Mutations.
    Beltran WA; Cideciyan AV; Boye SE; Ye GJ; Iwabe S; Dufour VL; Marinho LF; Swider M; Kosyk MS; Sha J; Boye SL; Peterson JJ; Witherspoon CD; Alexander JJ; Ying GS; Shearman MS; Chulay JD; Hauswirth WW; Gamlin PD; Jacobson SG; Aguirre GD
    Mol Ther; 2017 Aug; 25(8):1866-1880. PubMed ID: 28566226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Codon-Optimized RPGR Improves Stability and Efficacy of AAV8 Gene Therapy in Two Mouse Models of X-Linked Retinitis Pigmentosa.
    Fischer MD; McClements ME; Martinez-Fernandez de la Camara C; Bellingrath JS; Dauletbekov D; Ramsden SC; Hickey DG; Barnard AR; MacLaren RE
    Mol Ther; 2017 Aug; 25(8):1854-1865. PubMed ID: 28549772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A long-term efficacy study of gene replacement therapy for RPGR-associated retinal degeneration.
    Wu Z; Hiriyanna S; Qian H; Mookherjee S; Campos MM; Gao C; Fariss R; Sieving PA; Li T; Colosi P; Swaroop A
    Hum Mol Genet; 2015 Jul; 24(14):3956-70. PubMed ID: 25877300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a Molecularly Stable Gene Therapy Vector for the Treatment of
    Giacalone JC; Andorf JL; Zhang Q; Burnight ER; Ochoa D; Reutzel AJ; Collins MM; Sheffield VC; Mullins RF; Han IC; Stone EM; Tucker BA
    Hum Gene Ther; 2019 Aug; 30(8):967-974. PubMed ID: 31106594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Visual Function with Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa in the Randomized XIRIUS Phase 2/3 Study.
    Lam BL; Pennesi ME; Kay CN; Panda S; Gow JA; Zhao G; MacLaren RE;
    Ophthalmology; 2024 Sep; 131(9):1083-1093. PubMed ID: 38423215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy Evaluation of rAAV2tYF-PR1.7-hCNGA3 Vector Delivered by Subretinal Injection in CNGA3 Mutant Achromatopsia Sheep.
    Gootwine E; Ofri R; Banin E; Obolensky A; Averbukh E; Ezra-Elia R; Ross M; Honig H; Rosov A; Yamin E; Ye GJ; Knop DR; Robinson PM; Chulay JD; Shearman MS
    Hum Gene Ther Clin Dev; 2017 Jun; 28(2):96-107. PubMed ID: 28478700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase 1/2 AAV5-hRKp.RPGR (Botaretigene Sparoparvovec) Gene Therapy: Safety and Efficacy in RPGR-Associated X-Linked Retinitis Pigmentosa.
    Michaelides M; Besirli CG; Yang Y; DE Guimaraes TAC; Wong SC; Huckfeldt RM; Comander JI; Sahel JA; Shah SM; Tee JJL; Kumaran N; Georgiadis A; Minnick P; Zeldin R; Naylor S; Xu J; Clark M; Anglade E; Wong P; Fleck PR; Fung A; Peluso C; Kalitzeos A; Georgiou M; Ripamonti C; Smith AJ; Ali RR; Forbes A; Bainbridge J
    Am J Ophthalmol; 2024 Nov; 267():122-134. PubMed ID: 38871269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial.
    Ghazi NG; Abboud EB; Nowilaty SR; Alkuraya H; Alhommadi A; Cai H; Hou R; Deng WT; Boye SL; Almaghamsi A; Al Saikhan F; Al-Dhibi H; Birch D; Chung C; Colak D; LaVail MM; Vollrath D; Erger K; Wang W; Conlon T; Zhang K; Hauswirth W; Alkuraya FS
    Hum Genet; 2016 Mar; 135(3):327-43. PubMed ID: 26825853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AAV-RPGR Gene Therapy Rescues Opsin Mislocalisation in a Human Retinal Organoid Model of
    Sladen PE; Naeem A; Adefila-Ideozu T; Vermeule T; Busson SL; Michaelides M; Naylor S; Forbes A; Lane A; Georgiadis A
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging gene therapy products for RPGR-associated X-linked retinitis pigmentosa.
    Martinez-Fernandez de la Camara C; Cehajic-Kapetanovic J; MacLaren RE
    Expert Opin Emerg Drugs; 2022 Dec; 27(4):431-443. PubMed ID: 36562395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy rescues photoreceptor blindness in dogs and paves the way for treating human X-linked retinitis pigmentosa.
    Beltran WA; Cideciyan AV; Lewin AS; Iwabe S; Khanna H; Sumaroka A; Chiodo VA; Fajardo DS; Román AJ; Deng WT; Swider M; Alemán TS; Boye SL; Genini S; Swaroop A; Hauswirth WW; Jacobson SG; Aguirre GD
    Proc Natl Acad Sci U S A; 2012 Feb; 109(6):2132-7. PubMed ID: 22308428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term rescue of cone photoreceptor degeneration in retinitis pigmentosa 2 (RP2)-knockout mice by gene replacement therapy.
    Mookherjee S; Hiriyanna S; Kaneshiro K; Li L; Li Y; Li W; Qian H; Li T; Khanna H; Colosi P; Swaroop A; Wu Z
    Hum Mol Genet; 2015 Nov; 24(22):6446-58. PubMed ID: 26358772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the X-linked retinitis pigmentosa genes RPGR and RP2 found in 8.5% of families with a provisional diagnosis of autosomal dominant retinitis pigmentosa.
    Churchill JD; Bowne SJ; Sullivan LS; Lewis RA; Wheaton DK; Birch DG; Branham KE; Heckenlively JR; Daiger SP
    Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1411-6. PubMed ID: 23372056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in Retinal Sensitivity Associated With Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa With RPGR Gene Variations.
    von Krusenstiern L; Liu J; Liao E; Gow JA; Chen G; Ong T; Lotery AJ; Jalil A; Lam BL; MacLaren RE;
    JAMA Ophthalmol; 2023 Mar; 141(3):275-283. PubMed ID: 36757689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiprotein complexes of Retinitis Pigmentosa GTPase regulator (RPGR), a ciliary protein mutated in X-linked Retinitis Pigmentosa (XLRP).
    Murga-Zamalloa C; Swaroop A; Khanna H
    Adv Exp Med Biol; 2010; 664():105-14. PubMed ID: 20238008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-linked retinitis pigmentosa in two families with a missense mutation in the RPGR gene and putative change of glycine to valine at codon 60.
    Fishman GA; Grover S; Jacobson SG; Alexander KR; Derlacki DJ; Wu W; Buraczynska M; Swaroop A
    Ophthalmology; 1998 Dec; 105(12):2286-96. PubMed ID: 9855162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photoreceptor rescue by an abbreviated human RPGR gene in a murine model of X-linked retinitis pigmentosa.
    Pawlyk BS; Bulgakov OV; Sun X; Adamian M; Shu X; Smith AJ; Berson EL; Ali RR; Khani S; Wright AF; Sandberg MA; Li T
    Gene Ther; 2016 Feb; 23(2):196-204. PubMed ID: 26348595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.